Figure S4 from Bortezomib Restores Venetoclax Sensitivity in Acute Myeloid Leukemia Cell Lines with Intrinsic and Acquired Resistance
Year: 2026
Type: other
Abstract: The combination of venetoclax and bortezomib restores sensitivity of venetoclax in multiple acquired venetoclax resistant AML cells.
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7215717337